Mosekilde L - Search Results

1

Effects of PTH(1-84) therapy on muscle function and quality of life in hypoparathyroidism: results from a randomized controlled trial.

Sikjaer T, Rolighed L, Hess A, Fuglsang-Frederiksen A, Mosekilde L, Rejnmark L. Sikjaer T, et al. Among authors: mosekilde l. Osteoporos Int. 2014 Jun;25(6):1717-26. doi: 10.1007/s00198-014-2677-6. Epub 2014 Apr 1. Osteoporos Int. 2014. PMID: 24687385 Clinical Trial.

2

PTH replacement therapy of hypoparathyroidism.

Rejnmark L, Sikjaer T, Underbjerg L, Mosekilde L. Rejnmark L, et al. Among authors: mosekilde l. Osteoporos Int. 2013 May;24(5):1529-36. doi: 10.1007/s00198-012-2230-4. Epub 2012 Nov 27. Osteoporos Int. 2013. PMID: 23184178 Review.

3

Melatonin and the skeleton.

Amstrup AK, Sikjaer T, Mosekilde L, Rejnmark L. Amstrup AK, et al. Among authors: mosekilde l. Osteoporos Int. 2013 Dec;24(12):2919-27. doi: 10.1007/s00198-013-2404-8. Epub 2013 May 29. Osteoporos Int. 2013. PMID: 23716040 Review.

4

No effect of vitamin A intake on bone mineral density and fracture risk in perimenopausal women.

Rejnmark L, Vestergaard P, Charles P, Hermann AP, Brot C, Eiken P, Mosekilde L. Rejnmark L, et al. Among authors: mosekilde l. Osteoporos Int. 2004 Nov;15(11):872-80. doi: 10.1007/s00198-004-1618-1. Epub 2004 Mar 18. Osteoporos Int. 2004. PMID: 15034644 Clinical Trial.

5

Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture.

Vestergaard P, Rejnmark L, Mosekilde L. Vestergaard P, et al. Among authors: mosekilde l. Osteoporos Int. 2006;17(6):807-16. doi: 10.1007/s00198-005-0065-y. Epub 2006 Mar 7. Osteoporos Int. 2006. PMID: 16520889

6

No effect of vitamin K1 intake on bone mineral density and fracture risk in perimenopausal women.

Rejnmark L, Vestergaard P, Charles P, Hermann AP, Brot C, Eiken P, Mosekilde L. Rejnmark L, et al. Among authors: mosekilde l. Osteoporos Int. 2006;17(8):1122-32. doi: 10.1007/s00198-005-0044-3. Epub 2006 May 9. Osteoporos Int. 2006. PMID: 16683180

7

Fracture risk in patients treated with amiodarone or digoxin for cardiac arrhythmias: a nation-wide case-control study.

Rejnmark L, Vestergaard P, Mosekilde L. Rejnmark L, et al. Among authors: mosekilde l. Osteoporos Int. 2007 Apr;18(4):409-17. doi: 10.1007/s00198-006-0250-7. Epub 2006 Nov 9. Osteoporos Int. 2007. PMID: 17093893

8

Increased mortality in patients with a hip fracture-effect of pre-morbid conditions and post-fracture complications.

Vestergaard P, Rejnmark L, Mosekilde L. Vestergaard P, et al. Among authors: mosekilde l. Osteoporos Int. 2007 Dec;18(12):1583-93. doi: 10.1007/s00198-007-0403-3. Epub 2007 Jun 14. Osteoporos Int. 2007. PMID: 17566814

9

Use of bisphosphonates and raloxifene and risk of deep venous thromboembolism and pulmonary embolism.

Vestergaard P, Schwartz K, Pinholt EM, Rejnmark L, Mosekilde L. Vestergaard P, et al. Among authors: mosekilde l. Osteoporos Int. 2010 Sep;21(9):1591-7. doi: 10.1007/s00198-009-1091-y. Epub 2009 Oct 27. Osteoporos Int. 2010. PMID: 19859641

10

Stroke in relation to use of raloxifene and other drugs against osteoporosis.

Vestergaard P, Schwartz K, Pinholt EM, Rejnmark L, Mosekilde L. Vestergaard P, et al. Among authors: mosekilde l. Osteoporos Int. 2011 Apr;22(4):1037-45. doi: 10.1007/s00198-010-1276-4. Epub 2010 May 7. Osteoporos Int. 2011. PMID: 20449570

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

602 results

Search Page